With Genmab’s patents on Darzalex due to expire in the late 2020s and early 2030s, the stock market has taken fright at a forthcoming “patent cliff” likely to result in billions in lost ...

See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener. Silver Bullet ...